Index of reports
> Cases with Vomiting (79)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rebetol (Ribavirin) where reactions include vomiting. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 79 Next >>
Possible Rebetol side effects in
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient:
Reactions: Fatigue, Vomiting, Pruritus, Diarrhoea, Dehydration, Ephelides
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Peginterferon Alfa-2A
Dosage: 180 microgram, qw
Start date: 2012-03-24
Rebetol
Dosage: 1200 mg, qd
Administration route: Oral
Start date: 2012-03-24
Victrelis
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-21
Other drugs received by patient: Metformin HCL
Possible Rebetol side effects in
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient:
Reactions: White Blood Cell Count Decreased, Dyspnoea, Vomiting, RED Blood Cell Count Decreased, Nausea, Dizziness, Pallor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Peginterferon Alfa-2A
Dosage: 180 microgram, qw
Indication: Hepatitis C
Start date: 2011-10-21
Rebetol
Dosage: 1200 mg, qd
Indication: Hepatitis C
Start date: 2011-10-21
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2011-10-21
Possible Rebetol side effects in
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient:
Reactions: Abdominal Pain, Oral Mucosal Blistering, Vomiting, LIP Blister, Nausea, Muscle Spasms
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Start date: 2012-08-17
End date: 2012-08-19
Rebetol
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Renal Impairment, Vomiting, Nausea, Dizziness, General Physical Health Deterioration
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Glycyron
Dosage: 6 df, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-07-04
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-16
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-12
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-04-13
End date: 2012-04-16
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-16
Other drugs received by patient: Adalat CC; Olmesartan Medoxomil; Olmesartan Medoxomil; Loxonin; Loxonin; Adalat CC; Adalat CC; Glycyron; Doxazosin Mesylate; Metformin HCL; Kinedak; Adalat CC; Nesina; Loxonin; Potassium Chloride; Trichlormethiazide; Amaryl; Lendormin; Allopurinol; Trichlormethiazide; Vitamin E; Primperan TAB; Amaryl; Loxonin; Metformin HCL; Kinedak; Rohypnol; Doxazosin Mesylate; Nesina; Urso 250; Vitamin B12; Electrolytes (Unspecified) (+) Sodium Lactate; Lyrica; Lendormin D
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Vomiting
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
End date: 2012-04-16
PEG-Intron
Dosage: 1.5 ?g/kg, qw
Start date: 2012-03-14
End date: 2012-04-13
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-04-12
End date: 2012-04-16
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-14
End date: 2012-04-11
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-04-14
End date: 2012-04-16
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-14
End date: 2012-04-12
Telavic
Dosage: 1750 mg, qd
Administration route: Oral
Start date: 2012-04-13
End date: 2012-04-13
Other drugs received by patient: Dextrose (+) Electrolytes (Unspecified) (+) Sodium Lactate; Cyanocobalamin (+) Pyridoxine Hydrochloride (+) Thiamine Disulfide; Urso 250; Amino Acids (Unspecified); Fladd; Amlodipine Besylate; Selbex; Myser (Cycloserine); Ascorbic Acid; Olopatadine HCL; Neomallermin TR; Marzulene ES; Lansoprazole; Ascorbic Acid (+) Vitamin B Complex
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Malaise, Vomiting, Nausea, Anaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-04-18
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-05-07
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-05-08
End date: 2012-05-08
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-05-09
End date: 2012-05-14
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-05-15
Telavic
Dosage: 2250 mg, qd,cumulative dose 4500 mg
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-04-25
Telavic
Dosage: 1000 unk, unk,cumulative dose 4500 mg
Start date: 2012-06-13
End date: 2012-07-09
Telavic
Dosage: 1500 mg, qd,cumulative dose 4500 mg
Administration route: Oral
Start date: 2012-04-26
End date: 2012-06-12
Other drugs received by patient: Motilium; Eurax; Allegra; Clobetasol Propionate; Predonine; Predonine
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Renal Impairment, Vomiting, Nausea, General Physical Health Deterioration, Dizziness
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Glycyron
Dosage: 6 df, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-07-04
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-16
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-12
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-04-13
End date: 2012-04-16
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-16
Other drugs received by patient: Nesina; Metformin HCL; Adalat CC; Doxazosin Mesylate; Amaryl; Amaryl; Kinedak; Allopurinol; Olmesartan Medoxomil; Trichlormethiazide; Loxonin; Primperan TAB; Adalat CC; Olmesartan Medoxomil; Vitamin B12; Loxonin; Doxazosin Mesylate; Kinedak; Loxonin; Loxonin; Potassium Chloride; Lyrica; Lendormin D; Adalat CC; Metformin HCL; Lendormin; Rohypnol; Electrolytes (Unspecified) (+) Sodium Lactate; Glycyron; Trichlormethiazide; Nesina; Urso 250; Vitamin E; Adalat CC
Possible Rebetol side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Pruritus, Hypersensitivity, Contusion, Chills, Headache, Herpes Zoster, Vascular Injury, Fatigue, Malaise, Tongue Disorder, Candidiasis, Scratch, Swelling Face, Vomiting, Tongue Oedema, Nausea, Anaemia, Hypoaesthesia, Rash, Dysgeusia, Diarrhoea, Feeling Abnormal, Influenza
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-05-04
Rebetol
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-05-04
Valtrex
Dosage: unk unk, unknown
Indication: Herpes Zoster
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-06-01
Possible Rebetol side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Stomatitis, Vomiting, Diarrhoea, Headache
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-05
End date: 2012-08-01
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-05
Possible Rebetol side effects in
Reported by a individual with unspecified qualification from Japan on 2012-08-22
Patient:
Reactions: Vomiting, Renal Disorder, Nausea
Drug(s) suspected as cause:
Investigational Drug (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-03-05
End date: 2012-03-17
Investigational Drug (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-28
End date: 2012-03-01
Investigational Drug (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-03-27
End date: 2012-04-03
Investigational Drug (Unspecified)
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-04-04
PEG-Intron
Dosage: 1.3mcg/kg/week
Indication: Hepatitis C
Start date: 2012-02-28
PEG-Intron
Dosage: 1.5mcg/kg/week
Start date: 2012-02-24
End date: 2012-02-24
Peginterferon Alfa-2B
Dosage: 80 ?g/kg, qw
Indication: Hepatitis C
Start date: 2012-02-28
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-23
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-05
End date: 2012-03-17
Rebetol
Administration route: Oral
Start date: 2012-02-24
End date: 2012-02-27
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-28
End date: 2012-03-01
Telavic
Administration route: Oral
Start date: 2012-02-24
End date: 2012-02-26
Telavic
Administration route: Oral
Start date: 2012-03-27
End date: 2012-04-03
Telavic
Administration route: Oral
Start date: 2012-04-04
Telavic
Administration route: Oral
Start date: 2012-03-05
End date: 2012-03-17
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-28
End date: 2012-03-01
Other drugs received by patient: Warfarin Sodium; Urso 250; Digoxin; Urso 250; Nizatidine; Efonidipine Hydrochloride Ethanolate; Nizatidine; Diovan
Possible Rebetol side effects in
Reported by a physician from United States on 2012-08-13
Patient:
Reactions: Vomiting, Drug Ineffective, Pain in Extremity, Somnolence, Ulcer, Diarrhoea, Blood Potassium Decreased, Dehydration
Drug(s) suspected as cause:
Intron A
Dosage: unk unk, q3w
Indication: Hepatitis C
Start date: 2001-09-28
End date: 2002-09-27
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2001-09-28
End date: 2002-09-27
Possible Rebetol side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Vomiting, Dehydration, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Dosage: 180 microgram, unk
Rebetol
Dosage: 600 mg, bid
Administration route: Oral
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Possible Rebetol side effects in
Reported by a physician from United States on 2012-08-10
Patient:
Reactions: White Blood Cell Count Decreased, Dysgeusia, Weight Decreased, Vomiting, Nausea, Dehydration, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-07-01
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-07-01
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-10
Patient:
Reactions: Vomiting, Nausea, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.725mcg/kg/week
Start date: 2012-06-28
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-24
End date: 2012-06-21
Rebetol
Administration route: Oral
Start date: 2012-06-28
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-24
End date: 2012-06-27
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-24
End date: 2012-06-20
Telavic
Administration route: Oral
Start date: 2012-06-21
Other drugs received by patient: Amoban
Possible Rebetol side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Viral Load Increased, Vomiting, Contusion, Paranoia, Hyperhidrosis, Polyneuropathy, Joint Stiffness, Hallucination, Visual, Diarrhoea, Treatment Failure, Infection
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Start date: 2008-01-01
End date: 2008-07-01
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2006-12-01
End date: 2007-08-01
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2006-12-01
End date: 2007-08-01
Rebetol
Dosage: unk
Start date: 2008-01-01
End date: 2008-07-01
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-09
Patient:
Reactions: Vomiting, Dizziness, Hypoaesthesia, Headache
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-10
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-10
End date: 2012-05-27
Rebetol
Administration route: Oral
Start date: 2012-06-04
Rebetol
Administration route: Oral
Start date: 2012-05-28
End date: 2012-06-03
Telavic
Administration route: Oral
Start date: 2012-06-05
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-10
End date: 2012-06-03
Other drugs received by patient: Amlodipine Besylate; Famotidine; Laxoberon; Pursennid (Sennosides); Loxonin; Mucosta; Juvela; Evamyl; Aspirin
Possible Rebetol side effects in
Reported by a physician from United States on 2012-08-07
Patient:
Reactions: Weight Decreased, Fatigue, Vomiting, Chills, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-13
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-13
Victrelis
Indication: Hepatitis C
Other drugs received by patient: Zofran
Possible Rebetol side effects in
Reported by a pharmacist from United States on 2012-08-07
Patient:
Reactions: Weight Decreased, Dysgeusia, Vomiting, Fatigue, Arthralgia, Alopecia, Chromaturia, Rash, Muscle Twitching
Drug(s) suspected as cause:
Pegasys
Dosage: 180 microgram, qm
Indication: Hepatitis C
Start date: 2012-05-23
Rebetol
Dosage: 200 mg, unk
Victrelis
Dosage: 200 mg, unk
Possible Rebetol side effects in
Reported by a physician from United States on 2012-08-07
Patient:
Reactions: Weight Decreased, Fatigue, Vomiting, Pruritus, Nausea, Chills, Urticaria, Asthenia, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 microgram, qw
Indication: Hepatitis C
Start date: 2012-07-13
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-13
Other drugs received by patient: Zofran
Possible Rebetol side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06
Patient:
Reactions: White Blood Cell Count Decreased, Weight Decreased, Skin Injury, Vomiting, Drug Ineffective, Tooth Extraction, Tooth Infection, Headache, Haematemesis, Pain in JAW
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-05
Rebetol
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-05
Victrelis
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-03
End date: 2012-07-06
Possible Rebetol side effects in
Reported by a physician from United States on 2012-08-04
Patient:
Reactions: Vomiting, Nausea, Diarrhoea, Alopecia, Headache
Drug(s) suspected as cause:
Pegasys
Dosage: 180 microgram, unk
Start date: 2012-03-20
End date: 2012-07-01
Rebetol
Dosage: 400 mg, qpm
Start date: 2012-03-20
End date: 2012-07-01
Rebetol
Dosage: 600 mg, qam
Start date: 2012-03-20
End date: 2012-07-01
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-24
End date: 2012-07-01
Possible Rebetol side effects in
Reported by a consumer/non-health professional from United States on 2012-07-31
Patient:
Reactions: Aphagia, Vomiting, Diarrhoea, Hypokalaemia, Loss of Consciousness
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-04-26
Rebetol
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-04-26
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-07-30
Patient:
Reactions: Drug Eruption, Vomiting, Renal Impairment, Pruritus, Anaemia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.0mcg/kg
Indication: Hepatitis C
Start date: 2012-05-09
End date: 2012-05-16
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-09
End date: 2012-05-21
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-09
End date: 2012-05-18
Other drugs received by patient: Biofermin (Bacillus Subtilis (+) Lactobacillus Acidophilus (+) Strepto; Norvasc; Maglax (Magnesium Oxide); Flavitan
Possible Rebetol side effects in
Reported by a physician from United States on 2012-07-27
Patient:
Reactions: Bedridden, Chest Discomfort, Vomiting, Nausea, Retching, Anaemia, Oropharyngeal Pain, Pyrexia, DRY Skin, Anxiety, Weight Increased, Thinking Abnormal, Dehydration
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-01-31
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-01-31
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-02-28
Possible Rebetol side effects in
Reported by a physician from United States on 2012-07-27
Patient:
Reactions: Weight Decreased, Hypogeusia, Chills, Oropharyngeal Pain, Death, Cheilitis, Feeling of Body Temperature Change, Pharyngitis, White Blood Cell Count Decreased, Dysphagia, Vomiting, Stomatitis, Anaemia, Full Blood Count Decreased, Haemoglobin Decreased, Dysgeusia, Diarrhoea, Dehydration, Asthenia, Aphonia, Influenza Like Illness
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-04
End date: 2012-06-29
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-04
End date: 2012-06-29
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-08
End date: 2012-06-29
Possible Rebetol side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26
Patient:
Reactions: Weight Decreased, Vomiting, Fatigue
Drug(s) suspected as cause:
Rebetol
Dosage: 600 mg, bid
Administration route: Oral
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2012-06-05
End date: 2012-06-12
Other drugs received by patient: Pegasys
Possible Rebetol side effects in
Reported by a consumer/non-health professional from United States on 2012-07-16
Patient:
Reactions: Vomiting, Nausea, Anaemia, Headache, Scan Brain, Eating Disorder, Abdominal Pain Upper, Neck Pain, Vasculitis, Memory Impairment, Feeling Abnormal
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-09
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-09
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-07-13
Patient:
Reactions: Vomiting, Loss of Consciousness
Drug(s) suspected as cause:
PEG-Intron
Rebetol
Administration route: Oral
Telavic
Administration route: Oral
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-07-13
Patient:
Reactions: Vomiting, Nausea, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-09
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-09
End date: 2012-06-01
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-02
Telaprevir
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-05-18
End date: 2012-06-07
Telaprevir
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-09
End date: 2012-05-17
Other drugs received by patient: Micardis; Sefirom
Possible Rebetol side effects in 49 year old female
Reported by a physician from France on 2012-07-05
Patient: 49 year old female, weighing 59.4 kg (130.7 pounds)
Reactions: Productive Cough, Food Intolerance, Vomiting, Nausea, Hyperthermia, Anaemia, Pyrexia, Lung Disorder, Gastrointestinal Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neorecormon (Epoetin Beta)
Dosage: 30000 iu; biw
Start date: 2012-04-26
Rebetol
Dosage: 800 mg;qd; 600 mg; qd; 400 mg; qd
Indication: Hepatitis C
Start date: 2012-06-20
Rebetol
Dosage: 800 mg;qd; 600 mg; qd; 400 mg; qd
Indication: Hepatitis C
Start date: 2012-03-16
Rebetol
Dosage: 800 mg;qd; 600 mg; qd; 400 mg; qd
Indication: Hepatitis C
Start date: 2012-06-07
Victrelis
Dosage: 800 mg;tid
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-06-22
Viraferonpeg
Dosage: 80 mcg; qw;
Indication: Hepatitis C
Start date: 2012-03-16
End date: 2012-06-22
Other drugs received by patient: Drospirenone and Ethinyl Estradiol; Dexeryl; Isentress; Fortimel; Celluvisc; Mycoster; Viread; Emtriva; Acetaminophen
Page 1 Next >>
|